Dr Sarah Price
How often should women with Gestational Diabetes be testing?
What if my patient is already using the InnoLet insulin device?
What are the alternative insulins?
Are there any changes to short acting insulins?
Hypoglycaemia in Gestational Diabetes
Working with GPs
Dr Gary Deed
Quality care for people living with Gestational Diabetes
Working with your local maternity service
Emily Fitz
Discontinuation of Protaphane InnoLet insulin device
Education for women who have previously used Protaphane
Downloadable Resources

Videos will be available soon. Stay tuned!
Helping Women with GDM Safely Switch from InnoLet
Transitioning from InnoLet: What Every Health Professional Needs to Know
The InnoLet® insulin device was discontinued in Australia from February 2025, necessitating continued support from health professionals to ensure a safe, timely, and patient-centred transition to alternative insulin options or delivery systems. We have developed this short, practical video series featuring clinical experts Dr Sarah Price, Dr Gary Deed, and Emily Fitz, as a training resource that provides guidance. Please also note the ADIPS 2025 Consensus Recommendations for the screening and diagnosis of GDM that was published June 2025 in the MJA.
These video resources have been developed in collaboration with ADIPS, ADEA, RACGP, SOMANZ and Diabetes Australia and funded by an unrestricted grant from Novo Nordisk.
Part 1
Ramzi Ajjan
Over-the-Counter Continuous Glucose Monitoring – Data for All or a Disaster Waiting to Happen?
Ramzi Ajjan
If You Had to Pick Just One – GLP-1RA, GIP/GLP-1RA or SGLT2i for Type 2 Diabetes?
Day 4
Day 4 highlights will be available soon. Stay tuned!